Recently, the overexpression of TMEM16A in breast cancer and squamous cell carcinoma cells was reported to induce ERK1/2 phosphorylation, and knockdown of TMEM16A or use of inhibitors to reduce CaCC channel activity can reduce ERK1/2 activation [21]. Here, MAPK3 is linked to squamous cell carcinoma.